Y-Intercept (HK)’s Burning Rock Biotech BNR Stock Holding History

Y-Intercept (HK)’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,732	Closed	-$39K	–	1191
2022 Q4	$39K	Buy	1,732 +577	+50%	+$13.2K	0.01%	924
2022 Q3	$27.6K	Buy	+1,155	New	+$37.3K	﹤0.01%	918

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Y-Intercept (HK)'s BNR Position: Q1 2023 in Review

Y-Intercept (HK) sold out of Burning Rock Biotech (BNR) in Q1 2023, closing a stake of 1,732 shares — an estimated $39K sold.

Y-Intercept (HK) first reported a position in BNR in Q3 2022 and held it in 2 quarters. The position peaked at $39K in Q4 2022. 34 funds tracked by Wall St. Rank hold BNR as of Q1 2023.

Y-Intercept (HK) reported no remaining Burning Rock Biotech position as of Q1 2023 after selling out during the quarter.
Y-Intercept (HK) sold 1,732 Burning Rock Biotech shares in Q1 2023, an estimated $39K.
Y-Intercept (HK) first reported a position in Burning Rock Biotech in Q3 2022 and held it in 2 quarters.
Y-Intercept (HK)'s Burning Rock Biotech position peaked at $39K in Q4 2022.
34 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2023.

Based on Y-Intercept (HK)'s 13F filing for Q1 2023, filed 9 May 2023.